{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T20:30:09Z","timestamp":1778963409416,"version":"3.51.4"},"reference-count":10,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1016\/j.jinf.2016.05.009","type":"journal-article","created":{"date-parts":[[2016,6,11]],"date-time":"2016-06-11T23:07:37Z","timestamp":1465686457000},"page":"173-174","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Moxifloxacin should not be discounted in the treatment of bacterial meningitis"],"prefix":"10.1016","volume":"73","author":[{"given":"Melissa","family":"Baxter","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kim","family":"Jacobson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahableshwar","family":"Albur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jinf.2016.05.009_bib1","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.jinf.2016.01.007","article-title":"The UK joint specialist societies guideline on the diagnosis and management of acute meningitis and meningococcal sepsis in immunocompetent adults","volume":"72","author":"McGill","year":"2016","journal-title":"J Infect"},{"key":"10.1016\/j.jinf.2016.05.009_bib2","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1093\/jac\/dkl484","article-title":"Emerging fluoroquinolone resistance in Neisseria meningitidis in India: cause for concern","volume":"59","author":"Mehta","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jinf.2016.05.009_bib3","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1093\/jac\/47.4.411","article-title":"Activity of moxifloxacin against clinical isolates of Streptococcus pneumoniae from England and Wales","volume":"47","author":"Johnson","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jinf.2016.05.009_bib4","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1086\/319372","article-title":"Penicillin-resistant Streptococcus pneumoniae: review of moxifloxacin activity","volume":"32","author":"Dalhoff","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2016.05.009_bib5","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1056\/NEJMoa0806414","article-title":"Emergence of ciprofloxacin-resistant Neisseria meningitidis in North America","volume":"360","author":"Wu","year":"2009","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.jinf.2016.05.009_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/ofid\/ofv117","article-title":"Population-based surveillance of Neisseria meningitidis antimicrobial resistance in the United States","volume":"2","author":"Harcourt","year":"2015","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.jinf.2016.05.009_bib7","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1056\/NEJM199809243391302","article-title":"High-level chloramphenicol resistance in Neisseria meningitidis","volume":"339","author":"Galimand","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jinf.2016.05.009_bib8","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1093\/jac\/dkg452","article-title":"Chlorampheicol-resistant Neisseria meningitidis containing catP isolated in Australia","volume":"52","author":"Shlutz","year":"2003","journal-title":"J Antimicrob Chemother"},{"issue":"7","key":"10.1016\/j.jinf.2016.05.009_bib9","doi-asserted-by":"crossref","first-page":"3162","DOI":"10.1128\/JCM.43.7.3162-3171.2005","article-title":"Susceptibility of Neisseria meningitidis to 16 antimicrobial agents and characterization of resistance mechanisms affecting some agents","volume":"43","author":"Jorgensen","year":"2005","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.jinf.2016.05.009_bib10","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1093\/jac\/dku530","article-title":"Efficacy and safety of chloramphenicol: joining the revival of old antibiotics? Systematic review and meta-analysis of randomized controlled trials","volume":"70","author":"Eliakim-Raz","year":"2015","journal-title":"J Antimicrob Chemother"}],"container-title":["Journal of Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445316300949?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445316300949?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T21:23:13Z","timestamp":1759008193000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163445316300949"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":10,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,8]]}},"alternative-id":["S0163445316300949"],"URL":"https:\/\/doi.org\/10.1016\/j.jinf.2016.05.009","relation":{},"ISSN":["0163-4453"],"issn-type":[{"value":"0163-4453","type":"print"}],"subject":[],"published":{"date-parts":[[2016,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Moxifloxacin should not be discounted in the treatment of bacterial meningitis","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jinf.2016.05.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 The British Infection Association. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}